©
Shutterstock
A new research partnership between the Department of Psychiatry at the University of Oxford and ADM will explore emotional and cognitive effects of probiotics in perimenopausal women.
The research seeks to provide a deeper understanding of the links between the gut microbiome and the emotional and cognitive changes occurring during this period.
The research will add to a growing body of evidence on the effects of probiotics on mood and cognition and their ability to positively affect menopausal symptoms.
The eight-week trial, which has enrolled its first volunteer, will focus on the emotional and cognitive effects of a probiotic supplement containing 14 live bacterial strains in 106 perimenopausal women, building on existing evidence for this combination of probiotics on mood and cognitive and emotional processing.
The study is a randomised, double-blind, placebo-controlled study with volunteers randomised to receive either the probiotic or placebo. The emotional processing, cognitive function, subjective mood ratings and faecal microbiome of individuals taking part in the trial will be measured before and after taking the investigational products (the commercially available probiotic or the placebo).
Read the full story on the Department of Psychiatry website.